CurifyLabs, a healthtech company established in 2021 and headquartered in Helsinki, Finland, is at the forefront of 3D printing solutions for personalized medicine. The company's mission is to modernize the drug compounding process in pharmacies, offering sustainable and quality-controlled production of personalized medications. With a seasoned team boasting decades of expertise in pharmacy and pharmaceutical technology, CurifyLabs utilizes proprietary, patented printable inks to revolutionize compounding. Field-tested in major European markets such as Switzerland, Germany, Spain, and the Netherlands, the company envisions increasing personalized drug compounding from the current 1% to a significant 10%, meeting the rising demand for tailored medicine, particularly among under-served patient populations.